发明名称 |
Method for achieving desired glial growth factor 2 plasma levels |
摘要 |
The present invention relates to administering glial growth factor 2 (GGF2) to a patient in need thereof, to achieve serum levels of GGF2 within a desired therapeutic window determined based on the disease or disorder afflicting the patient. In a particular embodiment, the patient is suffering from a disease or disorder associated with reduced levels of myelination and the GGF2 is administered to promote myelination in the patient. |
申请公布号 |
AU2009217606(A1) |
申请公布日期 |
2009.09.03 |
申请号 |
AU20090217606 |
申请日期 |
2009.03.02 |
申请人 |
ACORDA THERAPEUTICS, INC. |
发明人 |
ANTHONY O. CAGGIANO;HAESUN KIM |
分类号 |
A61K38/28 |
主分类号 |
A61K38/28 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|